Clinical Trial

Estrogen Levels and Postoperative Recovery in IVF Patients

Completed
View on ClinicalTrials.gov →
Summary
This prospective observational study aims to evaluate the relationship between supraphysiologic serum estrogen levels and postoperative recovery quality in patients undergoing IVF procedures under general anesthesia. Estrogen is known to play a role in pain modulation and emotional responses, both of which influence postoperative recovery. The primary outcome is the quality of recovery score (QoR-15), and secondary outcomes include postoperative pain, nausea and vomiting, and discharge time. A total of 100 adult female patients will be included. The study seeks to provide better insight into how elevated estrogen levels may impact patient outcomes after anesthesia.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-07; most recent amendment 2025-12-31.
Status change: Recruiting → Completed 2025-12-31
Status change: Not Yet Recruiting → Recruiting 2025-04-30
Trial Details
NCT Number NCT06925633
Lead Sponsor Konya City Hospital
Conditions In Vitro Fertilization, Postoperative Recovery, Estrogens, Anesthesia Recovery Period
Enrollment 98 participants
Start Date 2025-04-20
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-06